These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37673913)

  • 1. A new class of anticancer activity with computational studies for a novel bioactive aminophosphonates based on pyrazole moiety.
    Baren MH; Ibrahim SA; Al-Rooqi MM; Ahmed SA; El-Gamil MM; Hekal HA
    Sci Rep; 2023 Sep; 13(1):14680. PubMed ID: 37673913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study.
    Farag PS; AboulMagd AM; Hemdan MM; Hassaballah AI
    Bioorg Chem; 2023 Jan; 130():106231. PubMed ID: 36335649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives.
    Alkamaly OM; Altwaijry N; Sabour R; Harras MF
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000351. PubMed ID: 33252142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent.
    Raut DG; Patil SB; Kadu VD; Hublikar MG; Bhosale RB
    Anticancer Agents Med Chem; 2018; 18(15):2117-2123. PubMed ID: 30417799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity.
    Riyadh SM; Farghaly TA; Abdallah MA; Abdalla MM; Abd El-Aziz MR
    Eur J Med Chem; 2010 Mar; 45(3):1042-50. PubMed ID: 20022411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and potent antimicrobial activity of novel coumarylthiazole α-aminophosphonates derivatives.
    Litim B; Cheraiet Z; Meliani S; Djahoudi A; Boukhari A
    Mol Divers; 2022 Apr; 26(2):1161-1174. PubMed ID: 34117993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
    Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
    Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies.
    Othman IMM; Alamshany ZM; Tashkandi NY; Gad-Elkareem MAM; Anwar MM; Nossier ES
    Bioorg Chem; 2021 Sep; 114():105078. PubMed ID: 34161878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer activity of some novel fused pyridine ring system.
    Elansary AK; Moneer AA; Kadry HH; Gedawy EM
    Arch Pharm Res; 2012 Nov; 35(11):1909-17. PubMed ID: 23212632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.
    Hassan AS; Moustafa GO; Awad HM; Nossier ES; Mady MF
    ACS Omega; 2021 May; 6(18):12361-12374. PubMed ID: 34056388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives.
    Metwally NH; Deeb EA
    Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
    Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
    Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
    Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
    Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities.
    El-Gohary NS; Hawas SS; Gabr MT; Shaaban MI; El-Ashmawy MB
    Bioorg Chem; 2019 Nov; 92():103109. PubMed ID: 31521987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.
    Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA
    Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.
    Galal SA; Abdelsamie AS; Shouman SA; Attia YM; Ali HI; Tabll A; El-Shenawy R; El Abd YS; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Girgis AS; El-Diwani HI
    Eur J Med Chem; 2017 Jul; 134():392-405. PubMed ID: 28433679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.